Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients
- 1 May 1992
- journal article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 85 (5) , 390-393
Abstract
A decreased incidence of cancer of the prostate has been demonstrated in a cohort of 6168 chronic schizophrenic patients followed up from 1957 to 1984. A case‐control study was performed based on this cohort to determine the possible influence of neuroleptic treatment and other factors on the risk of developing prostate cancer. Thirty‐eight male schizophrenic patients who had developed prostate cancer during the observation period were compared with 76 age‐ and sex‐matched controls from the same cohort. The only significant association was that of a reduced risk of prostate cancer among those who had been treated with a cumulative dose of high‐dose phenothiazines (primarily chlorpromazine) of 15 g or more. These patients had been treated with an average daily dose of 145 mg chlorpromazine for an average of 12.5 years. No other significant risk factors were identified.Keywords
This publication has 18 references indexed in Scilit:
- The incidence of cancer in schizophrenic patients.Journal of Epidemiology and Community Health, 1989
- Psychotropic medications in patients with cancerGeneral Hospital Psychiatry, 1987
- Cancer of the Prostate: Epidemiology and AetiologyBritish Journal of Urology, 1987
- Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patientsActa Psychiatrica Scandinavica, 1987
- A case-cohort design for epidemiologic cohort studies and disease prevention trialsBiometrika, 1986
- A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention TrialsBiometrika, 1986
- CHLORPROMAZINES AND CANCERThe Lancet, 1972
- Antitumor Activity of Psychotropic Drugs and Their Synergic Action with CyclophosphamideChemical and Pharmaceutical Bulletin, 1969
- Some epidemiological aspects of cancer of the prostateJournal of Chronic Diseases, 1963
- Har klorpromazin en cytostatisk verkan?Nordisk Psykiatrisk Tidsskrift, 1961